Abstract
MICs of DU-6859a, a novel fluoroquinolone, for 18 Klebsiella pneumoniae isolates and 21 Enterobacter cloacae isolates with altered GyrA or altered GyrA and ParC ranged from < or =0.025 to 6.25 microg/ml and from 0.1 to 3.13 microg/ml, respectively. Based on the MICs at which 90% of the isolates were inhibited for these strains of K. pneumoniae and E. cloacae, DU-6859a exhibited 16- to 256-fold-greater activity than currently available fluoroquinolones.
MeSH Terms
Anti-Infective Agents/pharmacology
DNA Gyrase
DNA Topoisomerase IV
DNA Topoisomerases, Type II/drug effects
Enterobacter cloacae/drug effects
Fluoroquinolones
Klebsiella pneumoniae/drug effects
Microbial Sensitivity Tests
Quinolones/pharmacology
Chemicals
Anti-Infective Agents
Fluoroquinolones
Quinolones
sitafloxacin
DNA Topoisomerase IV
DNA Gyrase
DNA Topoisomerases, Type II
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Deguchi T
Department of Urology, Gifu University School of Medicine, Japan.
Yasuda M
KawamuraT
Nakano M
Ozeki S
Kanematsu E
Nishino Y
Kawada Y
References (15)
15 references, click to expand
-
Mechanism of action of quinolones against Escherichia coli DNA gyrase.
Antimicrob Agents Chemother. 1993 Apr;37(4):839-45
PMID: 8388200
-
Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli.
Antimicrob Agents Chemother. 1993 Apr;37(4):696-701
PMID: 8388197
-
Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers.
Antimicrob Agents Chemother. 1995 Jan;39(1):170-4
PMID: 7695301
-
Topoisomerase IV is a target of quinolones in Escherichia coli.
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11801-5
PMID: 8524852
-
Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1995 Jul;39(7):1467-71
PMID: 7492087
-
Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.
Antimicrob Agents Chemother. 1996 Apr;40(4):879-85
PMID: 8849244
-
Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles.
Antimicrob Agents Chemother. 1996 Apr;40(4):1020-3
PMID: 8849219
-
Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC.
Antimicrob Agents Chemother. 1996 Jul;40(7):1741-4
PMID: 8807076
-
Effect of growth conditions on antimicrobial activity of DU-6859a and its bactericidal activity determined by the killing curve method.
J Antimicrob Chemother. 1996 Jun;37(6):1091-102
PMID: 8836812
-
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
Antimicrob Agents Chemother. 1996 Mar;40(3):710-14
PMID: 8851598
-
Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae.
Antimicrob Agents Chemother. 1997 Mar;41(3):699-701
PMID: 9056017
-
Antimicrobial activity of a new fluoroquinolone, DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV.
J Antimicrob Chemother. 1997 Feb;39(2):247-9
PMID: 9069547
-
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.
Antimicrob Agents Chemother. 1990 Jun;34(6):1271-2
PMID: 2168148
-
Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.
Antimicrob Agents Chemother. 1992 Jul;36(7):1491-8
PMID: 1324647
-
Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.
Mol Microbiol. 1994 Oct;14(2):371-80
PMID: 7830580